Table 3.

Dogs with PI thrombocytopenia (PI) and non‐PI dogs (dogs with either SI thrombocytopenia or nonimmune thrombocytopenia) were assessed for outcome measures

	PI dogs (n = 34)		Non‐PI dogs (n = 27)
Outcome measure	#/34	%	#/27	%	P‐value
Blood product administration	13	38.2	2	7.4	.007
Survival to discharge	31	91.2	25	92.6	.999
Outcome measure	Median	Range	Median	Range	P‐value
Hospitalization duration (days)	4.5	1–12	4	0–11	.974

Numbers and percentages of dogs that received blood products during hospitalization and that survived to discharge are presented, along with hospital duration (median and range; days). Values for outcomes that are significantly different between PI and non‐PI dogs (P < .05) are in bolded text.